Telemedicine and computers in diabetic retinopathy screening

Providing full screening of diabetic patients for retinopathy throughout the community would significantly reduce the incidence of blindness in this group of patients. However, although panretinal photocoagulation is of proved value in reversing or preventing neovascular complications and careful macular treatment prevents further visual loss, the resources or the infrastructure to detect appropriate patients for treatment are not universally available.1 The importance of the situation has been highlighted by the declaration of St Vincent, a European directive on the need to provide screening.2 3 An effective screening and treatment programme would ultimately reduce the burden on health and social service budgets because fewer of these relatively young patients would require long term support.4-6 Locally based efforts indicate that the key to diabetic retinopathy screening is efficiently obtaining images of the retina for classification. This raises two problems—firstly, the target population must be reached at minimum inconvenience to the patient and, secondly, the images must be assessed effectively. Care facilities for diabetic patients are spread throughout the community and so it is …

[1]  H. Mangurten,et al.  Cyclopia and other anomalies following maternal ingestion of salicylates. , 1980, The Journal of pediatrics.

[2]  N. Wald,et al.  Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. , 1989, BMJ.

[3]  R. Greenwood Population‐based Screening for Diabetic Retinopathy: a Promising Start , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[4]  R. Kavlock,et al.  Effects on the fetal rat eye of maternal benomyl exposure and protein malnutrition. , 1991, Current eye research.

[5]  M. Drummond,et al.  Optometrist screening for diabetic retinopathy: evidence and environment. , 1996, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[6]  W. Lenz A short history of thalidomide embryopathy. , 1988, Teratology.

[7]  David Myers,et al.  Neural Network Feature Detector For Real-Time Video Signal Processing , 1993, Int. J. Neural Syst..

[8]  J P Kerr,et al.  Medical image processing utilizing neural networks trained on a massively parallel computer. , 1995, Computers in biology and medicine.

[9]  R. Brent Methods of evaluating the alleged teratogenicity of environmental agents. , 1985, Progress in clinical and biological research.

[10]  T. Williamson,et al.  Automatic detection of diabetic retinopathy using an artificial neural network: a screening tool. , 1996, The British journal of ophthalmology.

[11]  D. Spiegelhalter,et al.  A Relative Cost‐effectiveness Analysis of Different Methods of Screening for Diabetic Retinopathy , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[12]  D. Singer,et al.  Screening for Diabetic Retinopathy , 1993, Diabetes Care.

[13]  A S Kapadia,et al.  Cost-Effectiveness of Alternative Methods for Diabetic Retinopathy Screening , 1992, Diabetes Care.

[14]  J C Javitt,et al.  Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. , 1989, Ophthalmology.

[15]  M J Buxton,et al.  Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. , 1992, Health economics.

[16]  D M Steinwachs,et al.  Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model. , 1990, Ophthalmology.